+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Acute Kidney Injury Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

  • ID: 4899056
  • Report
  • November 2019
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AM-Pharma BV
  • B. Braun Melsungen AG
  • LG Chem Ltd.
  • Merck & Co., Inc.
  • Novartis International AG
  • MORE
The report on the global acute kidney injury treatment market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global acute kidney injury treatment market to grow with a CAGR of 7.2% over the forecast period from 2019-2025. The study on acute kidney injury treatment market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on acute kidney injury treatment market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global acute kidney injury treatment market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global acute kidney injury treatment market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers
  • Rising prevalence of acute kidney injuries globally
  • Enhancement in acute kidney injury treatment
  • A surge in the number of clinical trials of drugs to treat acute kidney injury
2) Restraints
  • Side effects of drugs used in acute kidney injury treatment
3) Opportunities
  • Research and development promote innovations and advancements in acute kidney injury treatment
Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global acute kidney injury treatment market is segmented on the basis of type, treatment, and end-user.

The Global Acute Kidney Injury Treatment Market by Type
  • Prerenal Acute Kidney Injury
  • Postrenal Acute Kidney Injury
  • Intrinsic Renal Acute Kidney Injury
The Global Acute Kidney Injury Treatment Market by Treatment
  • Dialysis
  • Supportive Care
The Global Acute Kidney Injury Treatment Market by End-user
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End-users
Company Profiles

The companies covered in the report include
  • Quark Pharmaceuticals, Inc.
  • Baxter International, Inc.
  • AM-Pharma BV
  • LG Chem Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • Novartis International AG
  • Other Companies
What does this report deliver??
1. Comprehensive analysis of the global as well as regional markets of the acute kidney injury treatment market.
2. Complete coverage of all the segments in the acute kidney injury treatment market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global acute kidney injury treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AM-Pharma BV
  • B. Braun Melsungen AG
  • LG Chem Ltd.
  • Merck & Co., Inc.
  • Novartis International AG
  • MORE
1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Acute Kidney Injury Treatment Market Highlights
2.2. Acute Kidney Injury Treatment Market Projection
2.3. Acute Kidney Injury Treatment Market Regional Highlights

3. Global Acute Kidney Injury Treatment Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Type
3.4.2. Growth Matrix Analysis by Treatment
3.4.3. Growth Matrix Analysis by End-user
3.4.4. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Acute Kidney Injury Treatment Market

4. Acute Kidney Injury Treatment Market Macro Indicator Analysis

5. Global Acute Kidney Injury Treatment Market by Type
5.1. Prerenal Acute Kidney Injury
5.2. Postrenal Acute Kidney Injury
5.3. Intrinsic Renal Acute Kidney Injury

6. Global Acute Kidney Injury Treatment Market by Treatment
6.1. Dialysis
6.2. Supportive Care

7. Global Acute Kidney Injury Treatment Market by End-user
7.1. Hospitals
7.2. Ambulatory Surgical Centers
7.3. Other End-users

8. Global Acute Kidney Injury Treatment Market by Region 2019-2025
8.1. North America
8.1.1. North America Acute Kidney Injury Treatment Market by Type
8.1.2. North America Acute Kidney Injury Treatment Market by Treatment
8.1.3. North America Acute Kidney Injury Treatment Market by End-user
8.1.4. North America Acute Kidney Injury Treatment Market by Country
8.2. Europe
8.2.1. Europe Acute Kidney Injury Treatment Market by Type
8.2.2. Europe Acute Kidney Injury Treatment Market by Treatment
8.2.3. Europe Acute Kidney Injury Treatment Market by End-user
8.2.4. Europe Acute Kidney Injury Treatment Market by Country
8.3. Asia-Pacific
8.3.1. Asia-Pacific Acute Kidney Injury Treatment Market by Type
8.3.2. Asia-Pacific Acute Kidney Injury Treatment Market by Treatment
8.3.3. Asia-Pacific Acute Kidney Injury Treatment Market by End-user
8.3.4. Asia-Pacific Acute Kidney Injury Treatment Market by Country
8.4. RoW
8.4.1. RoW Acute Kidney Injury Treatment Market by Type
8.4.2. RoW Acute Kidney Injury Treatment Market by Treatment
8.4.3. RoW Acute Kidney Injury Treatment Market by End-user
8.4.4. RoW Acute Kidney Injury Treatment Market by Sub-region

9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Acute Kidney Injury Treatment Market
9.2. Companies Profiled
9.2.1. Quark Pharmaceuticals, Inc.
9.2.2. Baxter International, Inc.
9.2.3. AM-Pharma BV
9.2.4. LG Chem Ltd.
9.2.5. Fresenius Medical Care AG & Co. KGaA
9.2.6. Asahi Kasei Medical Co., Ltd.
9.2.7. B. Braun Melsungen AG
9.2.8. Teva Pharmaceutical Industries Ltd.
9.2.9. Merck & Co., Inc.
9.2.10. Novartis International AG
9.2.11. Other Companies

10. Appendix
10.1. Primary Research Findings and Questionnaire
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Quark Pharmaceuticals, Inc.
  • Baxter International, Inc.
  • AM-Pharma BV
  • LG Chem Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • Novartis International AG
Note: Product cover images may vary from those shown
Adroll
adroll